cas 76-83-5|| where to buy Triphenylmethyl chloride

Nom du produit:Triphenylmethyl chloride

IUPAC Name:

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM000181-500g	1-2 Weeks	ŢǤ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 76-83-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:76-83-5; Formule moléculaire:C19H15Cl; Point de fusion:-; Code SMILES:ClC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3; Densité:

: Numéro de catalogue:CM000181; Poids moléculaire:278.78; Point d'ébullition:; N° Mdl:MFCD00000813; Stockage:

: Zegocractin; CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.